Takeda Pharmaceutical Co Ltd

4502: XTKS (JPN)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|H?BLOCK|$$LOCK|C$#YyJ#

Takeda Earnings: In-Line Results Cap an Eventful Quarter of Pipeline Newsflow

Fiscal second-quarter revenue declined 1.6% year on year while core operating profit rose 1.9%. Reported revenue grew 6.7%, boosted by currency tailwinds. Management slightly raised its core operating profit forecast to JPY 1.19 trillion, or 2.6% higher, to reflect more currency benefit.

Sponsor Center